Literature DB >> 8285784

Intra-atrial calcium infusions, growth, and development in end organ resistance to vitamin D.

J P Lin1, W S Uttley.   

Abstract

A five and a half year follow up of a girl with end organ resistant rickets is described. After failing to respond to high dose oral alfacalcidol (4 micrograms/kg/day) and calcium supplements, treatment for one year with domiciliary intra-atrial calcium infusions at 2 years of age induced a complete remission, which was maintained on subsequent high dose oral calcium supplement. Overnight infusions were well tolerated without adverse cardiovascular or renal sequelae or ectopic calcification. If the first three years of life are survived, the prognosis for a normal life on oral treatment is excellent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8285784      PMCID: PMC1029657          DOI: 10.1136/adc.69.6.689

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

Review 1.  The role of the vitamin D endocrine system in health and disease.

Authors:  H Reichel; H P Koeffler; A W Norman
Journal:  N Engl J Med       Date:  1989-04-13       Impact factor: 91.245

2.  Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D.

Authors:  Y Weisman; I Bab; D Gazit; Z Spirer; M Jaffe; Z Hochberg
Journal:  Am J Med       Date:  1987-11       Impact factor: 4.965

3.  Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D: documentation and effective therapy with high dose intravenous calcium infusions.

Authors:  M Bliziotes; A L Yergey; M S Nanes; J Muenzer; M G Begley; N E Vieira; K K Kher; M L Brandi; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  1988-02       Impact factor: 5.958

4.  Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D.

Authors:  M H Brooks; N H Bell; L Love; P H Stern; E Orfei; S F Queener; A J Hamstra; H F DeLuca
Journal:  N Engl J Med       Date:  1978-05-04       Impact factor: 91.245

5.  Cloning and expression of full-length cDNA encoding human vitamin D receptor.

Authors:  A R Baker; D P McDonnell; M Hughes; T M Crisp; D J Mangelsdorf; M R Haussler; J W Pike; J Shine; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 6.  Molecular biology of the vitamin D hormone.

Authors:  M R Haussler; D J Mangelsdorf; B S Komm; C M Terpening; K Yamaoka; E A Allegretto; A R Baker; J Shine; D P McDonnell; M Hughes
Journal:  Recent Prog Horm Res       Date:  1988

7.  Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia.

Authors:  L J Fraher; R Karmali; F R Hinde; G N Hendy; H Jani; L Nicholson; D Grant; J L O'Riordan
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

8.  Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets.

Authors:  M R Hughes; P J Malloy; D G Kieback; R A Kesterson; J W Pike; D Feldman; B W O'Malley
Journal:  Science       Date:  1988-12-23       Impact factor: 47.728

9.  Calcium therapy for calcitriol-resistant rickets.

Authors:  Z Hochberg; D Tiosano; L Even
Journal:  J Pediatr       Date:  1992-11       Impact factor: 4.406

10.  Vitamin D is not directly necessary for bone growth and mineralization.

Authors:  J L Underwood; H F DeLuca
Journal:  Am J Physiol       Date:  1984-06
View more
  1 in total

1.  Vitamin D-Dependent Rickets Type II with Alopecia: A Rare Case Report.

Authors:  Divya Vupperla; Snehal Balvant Lunge; Praveen Elaprolu
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.